-
1
Pexidartinib treatment in Alexander disease model mice reduces macrophage numbers and increases glial fibrillary acidic protein levels, yet has minimal impact on other disease phen...
Published 2021-03-01Subjects: “…Pexidartinib…”
Get full text
Article -
2
Supporting patients in the transition to the revised pexidartinib dosing regimen: perspectives from the multidisciplinary clinical and allied health professional team
Published 2023-10-01Subjects: “…Pexidartinib…”
Get full text
Article -
3
Activated microglia and neuroinflammation as a pathogenic mechanism in Leigh syndrome
Published 2023-01-01Subjects: Get full text
Article -
4
Eco-Friendly, Simple, Fast, and Sensitive UPLC-MS/MS Method for Determination of Pexidartinib in Plasma and Its Application to Metabolic Stability
Published 2022-01-01Subjects: Get full text
Article -
5
Pexidartinib synergize PD-1 antibody through inhibiting treg infiltration by reducing TAM-derived CCL22 in lung adenocarcinoma
Published 2023-03-01Subjects: “…pexidartinib…”
Get full text
Article -
6
Pexidartinib Upfront in a Case of Tenosynovial Giant Cell Tumor: Proof of Concept for a Treatment Paradigm Shift
Published 2024-08-01Subjects: “…Pexidartinib…”
Get full text
Article -
7
Pexidartinib, a Novel Small Molecule CSF-1R Inhibitor in Use for Tenosynovial Giant Cell Tumor: A Systematic Review of Pre-Clinical and Clinical Development
Published 2020-05-01Subjects: “…pexidartinib…”
Get full text
Article -
8
Oxygen–Glucose Deprivation Increases NR4A1 Expression and Promotes Its Extranuclear Translocation in Mouse Astrocytes
Published 2024-02-01Subjects: Get full text
Article